Mycophenolate mofetil for the management of steroid-refractory acute graft vs host disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mycophenolate mofetil for the management of steroid-refractory acute graft vs host disease

Published:2009-09-21 Issue:5 Volume:45 Page:919-924
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Pidala J,Kim J,Perkins J,Field T,Fernandez H,Perez L,Ayala E,Kharfan-Dabaja M,Anasetti C

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2009252.pdf

Reference39 articles.

1. Hill GR, Ferrara JL . The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 2000; 95: 2754–2759.

2. MacMillan ML, Weisdorf DJ, Wagner JE, DeFor TE, Burns LJ, Ramsay NK et al. Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems. Biol Blood Marrow Transplant 2002; 8: 387–394.

3. Copelan EA . Hematopoietic stem cell transplantation. NEJM 2006; 354: 1813–1826.

4. Antin JH, Ferrara JL . Cytokine dysregulation and acute graft-versus-host disease. Blood 1992; 80: 2964–2968.

5. Chao NJ, Chen BJ . Prophylaxis and treatment of acute graft-versus-host disease. Semin Hematol 2006; 43: 32–41.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of ruxolitinib in steroid-refractory graft-versus-host disease: A meta-analysis;Frontiers in Immunology;2022-08-04

2.

Experimental Pharmaceuticals for Steroid-Refractory Acute Graft-versus-Host Disease

;Journal of Experimental Pharmacology;2020-11

3. Prognostic factors and long‐term follow‐up of basiliximab for steroid‐refractory acute graft‐versus‐host disease : Updated experience from a large‐scale study;American Journal of Hematology;2020-05-07

4. Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2020-05

5. Ruxolitinib: a potential treatment for corticosteroid refractory acute graft-versus-host disease;Expert Opinion on Investigational Drugs;2020-04-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3